Bionano Genomics (BNGO) Short-term Investments (2021 - 2025)
Bionano Genomics (BNGO) has disclosed Short-term Investments for 5 consecutive years, with $10.3 million as the latest value for Q4 2025.
- Quarterly Short-term Investments rose 3299.34% to $10.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.3 million through Dec 2025, up 3299.34% year-over-year, with the annual reading at $10.3 million for FY2025, 3299.34% up from the prior year.
- Short-term Investments hit $10.3 million in Q4 2025 for Bionano Genomics, down from $18.5 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $226.0 million in Q4 2021 to a low of $302000.0 in Q4 2024.
- Historically, Short-term Investments has averaged $73.0 million across 5 years, with a median of $29.0 million in 2023.
- Biggest five-year swings in Short-term Investments: tumbled 99.38% in 2024 and later soared 3299.34% in 2025.
- Year by year, Short-term Investments stood at $226.0 million in 2021, then tumbled by 32.76% to $152.0 million in 2022, then crashed by 67.88% to $48.8 million in 2023, then crashed by 99.38% to $302000.0 in 2024, then skyrocketed by 3299.34% to $10.3 million in 2025.
- Business Quant data shows Short-term Investments for BNGO at $10.3 million in Q4 2025, $18.5 million in Q3 2025, and $12.9 million in Q2 2025.